Journal Watch
New papers from 27 core journals plus medRxiv preprints, 05 Nov – 06 Nov 2026, for FRCPath trainees and trainers.
PubMed Entrez dates 5–6 Nov 2026 only; medRxiv infectious-disease preprints first published 4–6 Nov 2026 via the medRxiv API (Europe PMC returned none for that window; catch-up from preprint_pending_from 4 Nov). Papers already listed in prior issues are excluded. Summaries restate abstract text only; “not stated” means the record did not give it. Country is from the first author’s affiliation. Topic, study type, major-article section and FRCPath-relevance lines are automated labels. Preprints are not peer reviewed. No clinical advice is given.
Landmark studies0
None in this issue.
Cochrane reviews0
None in this issue.
Meta-analyses1
Vitamin D supplementation to prevent tuberculosis infection and disease: systematic review and individual participant data meta-analysis of randomised controlled trials
Key findings (from abstract)Four trials contributed IPD for 14,619 participants. Vitamin D did not reduce risk of incident tuberculosis infection (9,557 participants; aOR 0.97, 95% CI 0.81-1.18; p=0.79) or incident tuberculosis disease (14,533 participants; aOR 0.78, 95% CI 0.56-1.10; p=0.15). Vitamin D supplementation did not reduce the risk of incident tuberculosis infection or disease in the populations studied, either overall or within sub-groups. The 95% confidence interval of the effect estimate for prevention of tuberculosis disease remains compatible with a potentially important benefit, and further trials for this indication may be warranted.
FRCPath relevanceBacteriology content relevant to FRCPath Part 1/2 clinical bacteriology and pathogen-specific management.
Systematic reviews0
None in this issue.
Narrative reviews1
Combination antiviral treatment for a patient with lymphocytic choriomeningitis virus meningoencephalitis associated with bispecific antibody teclistamab therapy for myeloma.
Key findings (from abstract)The patient regained functional independence and returned to work, with only mild residual symptoms. In addition to reporting a novel occurrence of LCMV infection in a patient on teclistamab, the case highlights the presence of LCMV in the UK and the utility of metagenomic next-generation sequencing for pathogen identification in undiagnosed encephalitis. Finally, the case provides preliminary evidence supporting combination antiviral therapy in persistent LCMV infection.
FRCPath relevanceClinical virology content relevant to FRCPath virology/infection curricula (diagnosis, epidemiology, management).
Other major articles6
The evolution of carbapenem-resistant Klebsiella pneumoniae in Greek intensive care units is driven by local carbapenemase acquisition, nationwide nosocomial spread and emerging resistance to novel antimicrobials.
Key findings (from abstract)All isolates produced carbapenemases: 48% KPC, 20% NDM, 4.4% VIM, 27.6% multi-carbapenemase producers. Resistance to carbapenems, fluoroquinolones, aminoglycosides, and co-trimoxazole exceeded 90%, except for amikacin (73.4%) and colistin (46.5%). In Greek ICUs, CR-Kp appears to emerge via local plasmid acquisition and then spread within and between hospitals. While aztreonam-avibactam and cefepime-zidebactam remain promising treatment options, resistance among multi-carbapenemase producers and diagnostic gaps (notably for VEB variants) are concerning.
FRCPath relevanceInfection prevention and control content relevant to FRCPath IPC and outbreak-management competencies.
Viral Aetiology of Lower Respiratory Tract Infections in Infants Attending Primary Care in Eastern Spain, 2023-2025.
Key findings (from abstract)To describe seasonal patterns of respiratory viruses in infants presenting to primary care (PC) after the rollout of the RSV-immunisation programme in Spain, we analysed multiplex RT-PCR results from infants <1 year with lower respiratory tract infections (LRTIs) attending 57 PC centres in Valencia and Murcia across two seasons. Among the 307 infants, rhinovirus/enterovirus and RSV were the most common detections in both periods. hMPV, bocavirus, and influenza followed. Our findings highlight the importance of community-based surveillance systems for providing real-world evidence to inform future immunisation strategies.
FRCPath relevanceClinical virology content relevant to FRCPath virology/infection curricula (diagnosis, epidemiology, management).
Linezolid Minimum Inhibitory Concentration Creep and Precision Dosing in Older Adults: a longitudinal surveillance and multicentre population pharmacokinetic study.
Key findings (from abstract)Among 506 isolates, geometric mean minimum inhibitory concentration (MIC) increased from 1.587 to 1.796mg/L; the proportion at 2mg/L increased from 69.2% to 82.2%, whereas values ≤ 1mg/L decreased from 30.8% to 16.7%. Pharmacokinetic analysis included 406 patients and 1,032 samples; age and eGFR influenced clearance. Linezolid MICs shifted towards 2mg/L, while age and eGFR contributed to exposure variability. MIC-informed model-informed precision dosing, early therapeutic drug monitoring, and haematological monitoring may help balance efficacy and toxicity.
FRCPath relevanceAMR/antimicrobial stewardship content relevant to FRCPath antimicrobial therapy, susceptibility testing and AMS.
Diversity and host association of cfr-carrying plasmids of multidrug-resistant microorganisms from the Netherlands.
Key findings (from abstract)Dutch plasmids linked to plasmids from China, Denmark, the United States, South-Korea, Germany and Poland. Across all Dutch plasmids, the cfr-gene was flanked by transposable elements. The diversity among cfr-carrying plasmids in unrelated Dutch surveillance isolates and their relatedness to plasmids from countries in different global regions suggest multiple independent introductions into the Netherlands, although horizontal dissemination by transposons may contribute to their spread.
FRCPath relevanceAMR/antimicrobial stewardship content relevant to FRCPath antimicrobial therapy, susceptibility testing and AMS.
Biological Sex as a Determinant of Neurological Outcomes During Zika Virus Infection.
Key findings (from abstract)Given that many viral infections can lead to long-term neurological complications, it is crucial to understand how biological sex influences neuroinflammation. Using a mouse model of Zika virus infection, we find that males develop more severe clinical disease compared to females, despite comparable infectious viral loads. Our findings demonstrate that sexually dimorphic immune responses contribute to increased male susceptibility to virus-induced neuropathology.
FRCPath relevanceClinical virology content relevant to FRCPath virology/infection curricula (diagnosis, epidemiology, management).
Anti-HCV signal-to-cutoff ratio for predicting hepatitis C viremia in a hospital-based population and genotype distribution: A five-year single-center study.
Key findings (from abstract)Of 337,030 anti-HCV tests, 1,434 (0.42%) were reactive, and all were tested for HCV-RNA. Of these, 363 (0.11%) were viremic. Anti-HCV S/CO ratios predict the presence of viremia but not its magnitude. Furthermore, genotype 1b predominated in older age groups, while genotypes 4 and 5 were more frequently observed among patients of Syrian nationality.
FRCPath relevanceLaboratory diagnostics content relevant to FRCPath test evaluation, laboratory methods and quality.
Bacteria2
Vitamin D supplementation to prevent tuberculosis infection and disease: systematic review and individual participant data meta-analysis of randomised controlled trials
Key findings (from abstract)Four trials contributed IPD for 14,619 participants. Vitamin D did not reduce risk of incident tuberculosis infection (9,557 participants; aOR 0.97, 95% CI 0.81-1.18; p=0.79) or incident tuberculosis disease (14,533 participants; aOR 0.78, 95% CI 0.56-1.10; p=0.15). Vitamin D supplementation did not reduce the risk of incident tuberculosis infection or disease in the populations studied, either overall or within sub-groups. The 95% confidence interval of the effect estimate for prevention of tuberculosis disease remains compatible with a potentially important benefit, and further trials for this indication may be warranted.
FRCPath relevanceBacteriology content relevant to FRCPath Part 1/2 clinical bacteriology and pathogen-specific management.
A parsimonious machine-learning model using routine laboratory data to differentiate nontuberculous mycobacterial disease from tuberculosis: Development and independent external validation.
Key findings (from abstract)A post-hoc benchmark did not show an overall advantage for Extra Trees over other algorithms. Routine variables may help prioritize confirmatory testing, but the frozen threshold cannot support stand-alone diagnosis or exclusion of NTM. Prospective evaluation must verify patient-level measurement timing, reference diagnoses and clinical impact.
FRCPath relevanceBacteriology content relevant to FRCPath Part 1/2 clinical bacteriology and pathogen-specific management.
Virus4
Combination antiviral treatment for a patient with lymphocytic choriomeningitis virus meningoencephalitis associated with bispecific antibody teclistamab therapy for myeloma.
Key findings (from abstract)The patient regained functional independence and returned to work, with only mild residual symptoms. In addition to reporting a novel occurrence of LCMV infection in a patient on teclistamab, the case highlights the presence of LCMV in the UK and the utility of metagenomic next-generation sequencing for pathogen identification in undiagnosed encephalitis. Finally, the case provides preliminary evidence supporting combination antiviral therapy in persistent LCMV infection.
FRCPath relevanceClinical virology content relevant to FRCPath virology/infection curricula (diagnosis, epidemiology, management).
Viral Aetiology of Lower Respiratory Tract Infections in Infants Attending Primary Care in Eastern Spain, 2023-2025.
Key findings (from abstract)To describe seasonal patterns of respiratory viruses in infants presenting to primary care (PC) after the rollout of the RSV-immunisation programme in Spain, we analysed multiplex RT-PCR results from infants <1 year with lower respiratory tract infections (LRTIs) attending 57 PC centres in Valencia and Murcia across two seasons. Among the 307 infants, rhinovirus/enterovirus and RSV were the most common detections in both periods. hMPV, bocavirus, and influenza followed. Our findings highlight the importance of community-based surveillance systems for providing real-world evidence to inform future immunisation strategies.
FRCPath relevanceClinical virology content relevant to FRCPath virology/infection curricula (diagnosis, epidemiology, management).
Biological Sex as a Determinant of Neurological Outcomes During Zika Virus Infection.
Key findings (from abstract)Given that many viral infections can lead to long-term neurological complications, it is crucial to understand how biological sex influences neuroinflammation. Using a mouse model of Zika virus infection, we find that males develop more severe clinical disease compared to females, despite comparable infectious viral loads. Our findings demonstrate that sexually dimorphic immune responses contribute to increased male susceptibility to virus-induced neuropathology.
FRCPath relevanceClinical virology content relevant to FRCPath virology/infection curricula (diagnosis, epidemiology, management).
Accurate forecasting of the 2026 West Nile virus epidemic in Italy through mathematical modelling.
Key findings (from abstract)not stated (no abstract available in source record)
FRCPath relevanceClinical virology content relevant to FRCPath virology/infection curricula (diagnosis, epidemiology, management).
Mycology0
No papers in this topic today.
Infection control1
The evolution of carbapenem-resistant Klebsiella pneumoniae in Greek intensive care units is driven by local carbapenemase acquisition, nationwide nosocomial spread and emerging resistance to novel antimicrobials.
Key findings (from abstract)All isolates produced carbapenemases: 48% KPC, 20% NDM, 4.4% VIM, 27.6% multi-carbapenemase producers. Resistance to carbapenems, fluoroquinolones, aminoglycosides, and co-trimoxazole exceeded 90%, except for amikacin (73.4%) and colistin (46.5%). In Greek ICUs, CR-Kp appears to emerge via local plasmid acquisition and then spread within and between hospitals. While aztreonam-avibactam and cefepime-zidebactam remain promising treatment options, resistance among multi-carbapenemase producers and diagnostic gaps (notably for VEB variants) are concerning.
FRCPath relevanceInfection prevention and control content relevant to FRCPath IPC and outbreak-management competencies.
AMR/AMS6
Linezolid Minimum Inhibitory Concentration Creep and Precision Dosing in Older Adults: a longitudinal surveillance and multicentre population pharmacokinetic study.
Key findings (from abstract)Among 506 isolates, geometric mean minimum inhibitory concentration (MIC) increased from 1.587 to 1.796mg/L; the proportion at 2mg/L increased from 69.2% to 82.2%, whereas values ≤ 1mg/L decreased from 30.8% to 16.7%. Pharmacokinetic analysis included 406 patients and 1,032 samples; age and eGFR influenced clearance. Linezolid MICs shifted towards 2mg/L, while age and eGFR contributed to exposure variability. MIC-informed model-informed precision dosing, early therapeutic drug monitoring, and haematological monitoring may help balance efficacy and toxicity.
FRCPath relevanceAMR/antimicrobial stewardship content relevant to FRCPath antimicrobial therapy, susceptibility testing and AMS.
Diversity and host association of cfr-carrying plasmids of multidrug-resistant microorganisms from the Netherlands.
Key findings (from abstract)Dutch plasmids linked to plasmids from China, Denmark, the United States, South-Korea, Germany and Poland. Across all Dutch plasmids, the cfr-gene was flanked by transposable elements. The diversity among cfr-carrying plasmids in unrelated Dutch surveillance isolates and their relatedness to plasmids from countries in different global regions suggest multiple independent introductions into the Netherlands, although horizontal dissemination by transposons may contribute to their spread.
FRCPath relevanceAMR/antimicrobial stewardship content relevant to FRCPath antimicrobial therapy, susceptibility testing and AMS.
Re-securitising antimicrobial resistance: how resurgent health security thinking threatens collective action.
Key findings (from abstract)not stated (no abstract available in source record)
FRCPath relevanceAMR/antimicrobial stewardship content relevant to FRCPath antimicrobial therapy, susceptibility testing and AMS.
Therapeutic challenges in prosthetic valve Granulicatella adiacens endocarditis: a case report and focused review of alternative antimicrobial strategies.
Key findings (from abstract)Ceftriaxone-resistant PVIE was complicated by DRESS syndrome and linezolid-associated thrombocytopaenia. Treatment with ertapenem and levofloxacin was completed following surgery. Evidence supporting alternative treatment strategies for Granulicatella infections remains limited, highlighting the need for further research.
FRCPath relevanceAMR/antimicrobial stewardship content relevant to FRCPath antimicrobial therapy, susceptibility testing and AMS.
Comment on "Development of the Susceptibility-Spectrum Discrepancy Index (S2DI): A novel metric for antimicrobial stewardship in hospitalised patients".
Key findings (from abstract)not stated (no abstract available in source record)
FRCPath relevanceAMR/antimicrobial stewardship content relevant to FRCPath antimicrobial therapy, susceptibility testing and AMS.
In reply to the Letter to Editor regarding "Isavuconazole Prophylaxis and Treatment in Pediatric HSCT Recipients: Pharmacokinetics, Safety, and Efficacy".
Key findings (from abstract)not stated (no abstract available in source record)
FRCPath relevanceAMR/antimicrobial stewardship content relevant to FRCPath antimicrobial therapy, susceptibility testing and AMS.
Vaccines1
Humoral immunity after mRNA SARS-CoV-2 XFG vaccination.
Key findings (from abstract)not stated (no abstract available in source record)
FRCPath relevanceVaccinology content relevant to FRCPath immunisation and public-health microbiology.
Diagnostics1
Anti-HCV signal-to-cutoff ratio for predicting hepatitis C viremia in a hospital-based population and genotype distribution: A five-year single-center study.
Key findings (from abstract)Of 337,030 anti-HCV tests, 1,434 (0.42%) were reactive, and all were tested for HCV-RNA. Of these, 363 (0.11%) were viremic. Anti-HCV S/CO ratios predict the presence of viremia but not its magnitude. Furthermore, genotype 1b predominated in older age groups, while genotypes 4 and 5 were more frequently observed among patients of Syrian nationality.
FRCPath relevanceLaboratory diagnostics content relevant to FRCPath test evaluation, laboratory methods and quality.
Others1
Epstein-Barr virus influences the induction of protective antibody responses in young African children vaccinated with the RTS,S malaria vaccine
Key findings (from abstract)We evaluated whether latent CMV/EBV infections impact RTS,S-induced antibodies in 314 vaccinated children aged 5-29 months in West Africa. While no strong associations were observed for CMV, children seropositive for EBV had lower antigen-specific IgG and IgA, which have been linked with protective malaria immunity. These results may partly explain why malaria vaccines are suboptimal in populations where early CMV/EBV infections are prevalent.
FRCPath relevanceBroader infection science/epidemiology; background reading for FRCPath.
Diagnostic Microbiology and Infectious Disease3
Anti-HCV signal-to-cutoff ratio for predicting hepatitis C viremia in a hospital-based population and genotype distribution: A five-year single-center study.
Key findings (from abstract)Of 337,030 anti-HCV tests, 1,434 (0.42%) were reactive, and all were tested for HCV-RNA. Of these, 363 (0.11%) were viremic. Anti-HCV S/CO ratios predict the presence of viremia but not its magnitude. Furthermore, genotype 1b predominated in older age groups, while genotypes 4 and 5 were more frequently observed among patients of Syrian nationality.
FRCPath relevanceLaboratory diagnostics content relevant to FRCPath test evaluation, laboratory methods and quality.
A parsimonious machine-learning model using routine laboratory data to differentiate nontuberculous mycobacterial disease from tuberculosis: Development and independent external validation.
Key findings (from abstract)A post-hoc benchmark did not show an overall advantage for Extra Trees over other algorithms. Routine variables may help prioritize confirmatory testing, but the frozen threshold cannot support stand-alone diagnosis or exclusion of NTM. Prospective evaluation must verify patient-level measurement timing, reference diagnoses and clinical impact.
FRCPath relevanceBacteriology content relevant to FRCPath Part 1/2 clinical bacteriology and pathogen-specific management.
Therapeutic challenges in prosthetic valve Granulicatella adiacens endocarditis: a case report and focused review of alternative antimicrobial strategies.
Key findings (from abstract)Ceftriaxone-resistant PVIE was complicated by DRESS syndrome and linezolid-associated thrombocytopaenia. Treatment with ertapenem and levofloxacin was completed following surgery. Evidence supporting alternative treatment strategies for Granulicatella infections remains limited, highlighting the need for further research.
FRCPath relevanceAMR/antimicrobial stewardship content relevant to FRCPath antimicrobial therapy, susceptibility testing and AMS.
International Journal of Antimicrobial Agents3
Diversity and host association of cfr-carrying plasmids of multidrug-resistant microorganisms from the Netherlands.
Key findings (from abstract)Dutch plasmids linked to plasmids from China, Denmark, the United States, South-Korea, Germany and Poland. Across all Dutch plasmids, the cfr-gene was flanked by transposable elements. The diversity among cfr-carrying plasmids in unrelated Dutch surveillance isolates and their relatedness to plasmids from countries in different global regions suggest multiple independent introductions into the Netherlands, although horizontal dissemination by transposons may contribute to their spread.
FRCPath relevanceAMR/antimicrobial stewardship content relevant to FRCPath antimicrobial therapy, susceptibility testing and AMS.
Comment on "Development of the Susceptibility-Spectrum Discrepancy Index (S2DI): A novel metric for antimicrobial stewardship in hospitalised patients".
Key findings (from abstract)not stated (no abstract available in source record)
FRCPath relevanceAMR/antimicrobial stewardship content relevant to FRCPath antimicrobial therapy, susceptibility testing and AMS.
In reply to the Letter to Editor regarding "Isavuconazole Prophylaxis and Treatment in Pediatric HSCT Recipients: Pharmacokinetics, Safety, and Efficacy".
Key findings (from abstract)not stated (no abstract available in source record)
FRCPath relevanceAMR/antimicrobial stewardship content relevant to FRCPath antimicrobial therapy, susceptibility testing and AMS.
Journal of Infection3
The evolution of carbapenem-resistant Klebsiella pneumoniae in Greek intensive care units is driven by local carbapenemase acquisition, nationwide nosocomial spread and emerging resistance to novel antimicrobials.
Key findings (from abstract)All isolates produced carbapenemases: 48% KPC, 20% NDM, 4.4% VIM, 27.6% multi-carbapenemase producers. Resistance to carbapenems, fluoroquinolones, aminoglycosides, and co-trimoxazole exceeded 90%, except for amikacin (73.4%) and colistin (46.5%). In Greek ICUs, CR-Kp appears to emerge via local plasmid acquisition and then spread within and between hospitals. While aztreonam-avibactam and cefepime-zidebactam remain promising treatment options, resistance among multi-carbapenemase producers and diagnostic gaps (notably for VEB variants) are concerning.
FRCPath relevanceInfection prevention and control content relevant to FRCPath IPC and outbreak-management competencies.
Linezolid Minimum Inhibitory Concentration Creep and Precision Dosing in Older Adults: a longitudinal surveillance and multicentre population pharmacokinetic study.
Key findings (from abstract)Among 506 isolates, geometric mean minimum inhibitory concentration (MIC) increased from 1.587 to 1.796mg/L; the proportion at 2mg/L increased from 69.2% to 82.2%, whereas values ≤ 1mg/L decreased from 30.8% to 16.7%. Pharmacokinetic analysis included 406 patients and 1,032 samples; age and eGFR influenced clearance. Linezolid MICs shifted towards 2mg/L, while age and eGFR contributed to exposure variability. MIC-informed model-informed precision dosing, early therapeutic drug monitoring, and haematological monitoring may help balance efficacy and toxicity.
FRCPath relevanceAMR/antimicrobial stewardship content relevant to FRCPath antimicrobial therapy, susceptibility testing and AMS.
Accurate forecasting of the 2026 West Nile virus epidemic in Italy through mathematical modelling.
Key findings (from abstract)not stated (no abstract available in source record)
FRCPath relevanceClinical virology content relevant to FRCPath virology/infection curricula (diagnosis, epidemiology, management).
The Journal of Infectious Diseases2
Viral Aetiology of Lower Respiratory Tract Infections in Infants Attending Primary Care in Eastern Spain, 2023-2025.
Key findings (from abstract)To describe seasonal patterns of respiratory viruses in infants presenting to primary care (PC) after the rollout of the RSV-immunisation programme in Spain, we analysed multiplex RT-PCR results from infants <1 year with lower respiratory tract infections (LRTIs) attending 57 PC centres in Valencia and Murcia across two seasons. Among the 307 infants, rhinovirus/enterovirus and RSV were the most common detections in both periods. hMPV, bocavirus, and influenza followed. Our findings highlight the importance of community-based surveillance systems for providing real-world evidence to inform future immunisation strategies.
FRCPath relevanceClinical virology content relevant to FRCPath virology/infection curricula (diagnosis, epidemiology, management).
Biological Sex as a Determinant of Neurological Outcomes During Zika Virus Infection.
Key findings (from abstract)Given that many viral infections can lead to long-term neurological complications, it is crucial to understand how biological sex influences neuroinflammation. Using a mouse model of Zika virus infection, we find that males develop more severe clinical disease compared to females, despite comparable infectious viral loads. Our findings demonstrate that sexually dimorphic immune responses contribute to increased male susceptibility to virus-induced neuropathology.
FRCPath relevanceClinical virology content relevant to FRCPath virology/infection curricula (diagnosis, epidemiology, management).
The Lancet Infectious Diseases2
Combination antiviral treatment for a patient with lymphocytic choriomeningitis virus meningoencephalitis associated with bispecific antibody teclistamab therapy for myeloma.
Key findings (from abstract)The patient regained functional independence and returned to work, with only mild residual symptoms. In addition to reporting a novel occurrence of LCMV infection in a patient on teclistamab, the case highlights the presence of LCMV in the UK and the utility of metagenomic next-generation sequencing for pathogen identification in undiagnosed encephalitis. Finally, the case provides preliminary evidence supporting combination antiviral therapy in persistent LCMV infection.
FRCPath relevanceClinical virology content relevant to FRCPath virology/infection curricula (diagnosis, epidemiology, management).
Humoral immunity after mRNA SARS-CoV-2 XFG vaccination.
Key findings (from abstract)not stated (no abstract available in source record)
FRCPath relevanceVaccinology content relevant to FRCPath immunisation and public-health microbiology.
medRxiv (preprint, not peer reviewed)2
Vitamin D supplementation to prevent tuberculosis infection and disease: systematic review and individual participant data meta-analysis of randomised controlled trials
Key findings (from abstract)Four trials contributed IPD for 14,619 participants. Vitamin D did not reduce risk of incident tuberculosis infection (9,557 participants; aOR 0.97, 95% CI 0.81-1.18; p=0.79) or incident tuberculosis disease (14,533 participants; aOR 0.78, 95% CI 0.56-1.10; p=0.15). Vitamin D supplementation did not reduce the risk of incident tuberculosis infection or disease in the populations studied, either overall or within sub-groups. The 95% confidence interval of the effect estimate for prevention of tuberculosis disease remains compatible with a potentially important benefit, and further trials for this indication may be warranted.
FRCPath relevanceBacteriology content relevant to FRCPath Part 1/2 clinical bacteriology and pathogen-specific management.
Epstein-Barr virus influences the induction of protective antibody responses in young African children vaccinated with the RTS,S malaria vaccine
Key findings (from abstract)We evaluated whether latent CMV/EBV infections impact RTS,S-induced antibodies in 314 vaccinated children aged 5-29 months in West Africa. While no strong associations were observed for CMV, children seropositive for EBV had lower antigen-specific IgG and IgA, which have been linked with protective malaria immunity. These results may partly explain why malaria vaccines are suboptimal in populations where early CMV/EBV infections are prevalent.
FRCPath relevanceBroader infection science/epidemiology; background reading for FRCPath.
The Lancet Microbe1
Re-securitising antimicrobial resistance: how resurgent health security thinking threatens collective action.
Key findings (from abstract)not stated (no abstract available in source record)
FRCPath relevanceAMR/antimicrobial stewardship content relevant to FRCPath antimicrobial therapy, susceptibility testing and AMS.
American Journal of Infection Control0
No new records from this journal in today’s window.
Antimicrobial Agents and Chemotherapy0
No new records from this journal in today’s window.
Antimicrobial Resistance & Infection Control0
No new records from this journal in today’s window.
Clinical Infectious Diseases0
No new records from this journal in today’s window.
Clinical Microbiology Reviews0
No new records from this journal in today’s window.
Clinical Microbiology and Infection0
No new records from this journal in today’s window.
Emerging Infectious Diseases0
No new records from this journal in today’s window.
European Journal of Clinical Microbiology & Infectious Diseases0
No new records from this journal in today’s window.
Infection Control & Hospital Epidemiology0
No new records from this journal in today’s window.
Infection Prevention in Practice (IPIP)0
No new records from this journal in today’s window.
JAC-Antimicrobial Resistance0
No new records from this journal in today’s window.
Journal of Antimicrobial Chemotherapy0
No new records from this journal in today’s window.
Journal of Clinical Microbiology0
No new records from this journal in today’s window.
Journal of Clinical Virology0
No new records from this journal in today’s window.
Journal of Hospital Infection0
No new records from this journal in today’s window.
Journal of Infection Prevention0
No new records from this journal in today’s window.
Journal of Medical Microbiology0
No new records from this journal in today’s window.
Medical Mycology0
No new records from this journal in today’s window.
Nature Microbiology0
No new records from this journal in today’s window.
Open Forum Infectious Diseases0
No new records from this journal in today’s window.
mBio0
No new records from this journal in today’s window.
Sources searched27 journals + medRxiv
Window: PubMed Entrez date 05 Nov – 06 Nov 2026; medRxiv first publication date 05 Nov – 06 Nov 2026. Papers already listed in earlier issues are excluded. All queries succeeded.
| Source | Abbrev. | Via | Papers today |
|---|---|---|---|
| Journal of Infection | J Infect | PubMed | 3 |
| The Lancet Infectious Diseases | Lancet Infect Dis | PubMed | 2 |
| Clinical Infectious Diseases | Clin Infect Dis | PubMed | 0 |
| The Journal of Infectious Diseases | J Infect Dis | PubMed | 2 |
| Clinical Microbiology and Infection | Clin Microbiol Infect | PubMed | 0 |
| Open Forum Infectious Diseases | Open Forum Infect Dis | PubMed | 0 |
| Emerging Infectious Diseases | Emerg Infect Dis | PubMed | 0 |
| Clinical Microbiology Reviews | Clin Microbiol Rev | PubMed | 0 |
| Journal of Clinical Microbiology | J Clin Microbiol | PubMed | 0 |
| The Lancet Microbe | Lancet Microbe | PubMed | 1 |
| Journal of Medical Microbiology | J Med Microbiol | PubMed | 0 |
| Nature Microbiology | Nat Microbiol | PubMed | 0 |
| mBio | mBio | PubMed | 0 |
| Diagnostic Microbiology and Infectious Disease | Diagn Microbiol Infect Dis | PubMed | 3 |
| European Journal of Clinical Microbiology & Infectious Diseases | Eur J Clin Microbiol Infect Dis | PubMed | 0 |
| Journal of Hospital Infection | J Hosp Infect | PubMed | 0 |
| Infection Prevention in Practice (IPIP) | Infect Prev Pract | PubMed | 0 |
| Infection Control & Hospital Epidemiology | Infect Control Hosp Epidemiol | PubMed | 0 |
| American Journal of Infection Control | Am J Infect Control | PubMed | 0 |
| Antimicrobial Resistance & Infection Control | Antimicrob Resist Infect Control | PubMed | 0 |
| Journal of Infection Prevention | J Infect Prev | PubMed | 0 |
| Journal of Antimicrobial Chemotherapy | J Antimicrob Chemother | PubMed | 0 |
| Antimicrobial Agents and Chemotherapy | Antimicrob Agents Chemother | PubMed | 0 |
| International Journal of Antimicrobial Agents | Int J Antimicrob Agents | PubMed | 3 |
| JAC-Antimicrobial Resistance | JAC Antimicrob Resist | PubMed | 0 |
| Journal of Clinical Virology | J Clin Virol | PubMed | 0 |
| Medical Mycology | Med Mycol | PubMed | 0 |
| medRxiv (infectious-disease preprints) | via Europe PMC | Europe PMC | 2 |
| Total | 16 | ||